Akers Biosciences Allowed US Patent for Akers Wellness(TM) Tests Cartridge

THOROFARE, NJ--(Marketwired - Feb 16, 2017) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces that the United States Patent and Trademark Office has allowed a patent covering Akers Bio's proprietary cartridge for the optical scanning device utilized in the Company's BreathScan Lync™ technology. BreathScan Lync™ is the new bluetooth-enabled reading device from Akers Wellness™ which enables users to track the results of Akers Wellness™ breath-based tests via their mobile device.

The patent covers the unique design of the disposable cartridge which contains the reagent for the detection of wellness markers. The reagent contained within is analyzed using optical scanning technology after contact with the user's exhaled breath sample and produces a quantitative result through the Akers Wellness™ app on the user's smartphone or tablet. Included in the patent are the unique form factor, optical lens and read elements and the unique 'U' shaped airflow pathway.

Akers Wellness™ breath tests, such as BreathScan OxiChek™ and BreathScan KetoChek™, are designed to help promote, track and/or encourage choices related to general health and wellbeing; or to support weight loss.

Update on Commercialization of Akers Wellness™ Tests

OxiChek™ is now fully commercialized and selling through the Company's distributor, Aero-Med, to anti-aging, functional and integrative health and wellness treatment practitioners in the US.

OxiChek™ is the first disposable breath test to rapidly determine levels of oxidative stress in the body by measuring the levels of certain abundant free radicals. Frequent use of OxiChek™ may help health practitioners to monitor and adjust their clients' regimen of nutritional supplementation in order to manage oxidative stress -- an indicator of the overall health and wellbeing of a person.

The Company is ramping up marketing initiatives of OxiChek™ to professionals through enhanced e-commerce and social media platforms as well as through participation in large trade shows targeting naturopaths, wellness coaches, anti-aging practitioners, nutritionists and chiropractors.

In addition to targeting professionals, Akers Wellness™ intends to start marketing OxiChek™ through direct-to-consumer channels during 2017. This will include a television marketing campaign through the popular Balancing Act national television show on the Lifetime network. Balancing Act is America's premier morning show that introduces positive solutions to busy, on-the-go modern women. Akers Wellness™ has completed filming of the program, which will be aired multiple times on Lifetime during Q2 2017 and syndicated to approximately 200 affiliates. This marketing initiative is targeting women aged 25-45 and will potentially reach approximately 98 million households and thousands of online viewers.